In MH7A cells, retinoic acid-platinum (II) complex (0.25–12 μM) downregulated the activation of the MEK/NF-κB pathway [90], whereas sclareol exhibited anti-RA potential in collagen-induced arthritis in vivo and in vitro models [74]. Here, NFKB1 is linked to arthritic joint disease.